EUDAW
EUDA Health Holdings LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.68
52W High
$0.15
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-40.70%
Forward P/E
—
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is an innovative biotechnology company focused on creating advanced therapies for dermatological and chronic health conditions. Leveraging scientific innovation and technology, EUDA is dedicated to addressing significant unmet medical needs with its robust pipeline of transformative products. Guided by a highly experienced leadership team, the company is strategically poised to seize growth opportunities in the dynamic healthcare sector, ultimately striving to enhance patient outcomes and quality of life.
Fundamentals
| Revenue (TTM) | $6.82M |
| Gross Profit (TTM) | $2.99M |
| EBITDA | $-2.24M |
| Operating Margin | -34.80% |
| Return on Equity | 0.00% |
| Return on Assets | -89.30% |
| Revenue/Share (TTM) | $3.65 |
| Book Value | $-2.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 78.90% |
| Shares Outstanding | 0 |
| Float | $1.11M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
166.79%
HV 20-Day
205.52%
HV 30-Day
191.94%
HV 60-Day
186.12%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EUDAW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026